Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

10thpctl

Volume

0.28×avg

Market Cap

12.12MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Continue with finqOS

Explore Plus Therapeutics, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Plus Therapeutics, Inc.

PSTVNASDAQ Capital Market·USD·Closed

Plus Therapeutics, Inc.

PSTVNASDAQ·USD·Closed

$5.01

−7.56%

$5.01

−$0.41 (7.56%)

52W Range

10thpctl

Volume

0.28×avg

Mkt Cap

12.12MUSD

P/E

-2.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

PSTV: Plus Therapeutics, Inc. Financial Statements & Revenue | finqOS